WO1992013101A1 - Procede de detection de la variation de sequences d'adn - Google Patents
Procede de detection de la variation de sequences d'adn Download PDFInfo
- Publication number
- WO1992013101A1 WO1992013101A1 PCT/NL1992/000018 NL9200018W WO9213101A1 WO 1992013101 A1 WO1992013101 A1 WO 1992013101A1 NL 9200018 W NL9200018 W NL 9200018W WO 9213101 A1 WO9213101 A1 WO 9213101A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- dna
- alu
- pcr
- repeat
- inter
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 51
- 108091028043 Nucleic acid sequence Proteins 0.000 title description 6
- 108020004414 DNA Proteins 0.000 claims abstract description 97
- 239000012634 fragment Substances 0.000 claims abstract description 40
- 239000000523 sample Substances 0.000 claims abstract description 40
- 238000009396 hybridization Methods 0.000 claims abstract description 32
- 210000000349 chromosome Anatomy 0.000 claims abstract description 26
- 238000004458 analytical method Methods 0.000 claims abstract description 19
- 239000012528 membrane Substances 0.000 claims abstract description 19
- 230000004544 DNA amplification Effects 0.000 claims abstract description 14
- 108091023043 Alu Element Proteins 0.000 claims abstract description 10
- 230000007614 genetic variation Effects 0.000 claims abstract description 9
- 108091027544 Subgenomic mRNA Proteins 0.000 claims abstract description 6
- 239000003298 DNA probe Substances 0.000 claims abstract description 5
- 108020004518 RNA Probes Proteins 0.000 claims abstract description 5
- 239000003391 RNA probe Substances 0.000 claims abstract description 5
- 238000000926 separation method Methods 0.000 claims description 51
- 238000003752 polymerase chain reaction Methods 0.000 claims description 39
- 210000004754 hybrid cell Anatomy 0.000 claims description 17
- 210000001106 artificial yeast chromosome Anatomy 0.000 claims description 8
- 210000002230 centromere Anatomy 0.000 claims description 6
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 4
- 108091081062 Repeated sequence (DNA) Proteins 0.000 claims description 4
- 108091035539 telomere Proteins 0.000 claims description 3
- 210000003411 telomere Anatomy 0.000 claims description 3
- 102000055501 telomere Human genes 0.000 claims description 3
- 229960002685 biotin Drugs 0.000 claims description 2
- 235000020958 biotin Nutrition 0.000 claims description 2
- 239000011616 biotin Substances 0.000 claims description 2
- SHIBSTMRCDJXLN-KCZCNTNESA-N digoxigenin Chemical compound C1([C@@H]2[C@@]3([C@@](CC2)(O)[C@H]2[C@@H]([C@@]4(C)CC[C@H](O)C[C@H]4CC2)C[C@H]3O)C)=CC(=O)OC1 SHIBSTMRCDJXLN-KCZCNTNESA-N 0.000 claims description 2
- 239000000126 substance Substances 0.000 claims description 2
- 238000012546 transfer Methods 0.000 abstract description 3
- 238000001514 detection method Methods 0.000 abstract description 2
- 238000000539 two dimensional gel electrophoresis Methods 0.000 abstract description 2
- 239000000047 product Substances 0.000 description 28
- 241000282414 Homo sapiens Species 0.000 description 24
- 239000000499 gel Substances 0.000 description 18
- 239000000203 mixture Substances 0.000 description 13
- 238000002474 experimental method Methods 0.000 description 11
- 210000003917 human chromosome Anatomy 0.000 description 11
- 238000006243 chemical reaction Methods 0.000 description 9
- 239000003550 marker Substances 0.000 description 9
- 241000196324 Embryophyta Species 0.000 description 8
- 241001465754 Metazoa Species 0.000 description 8
- 238000012408 PCR amplification Methods 0.000 description 8
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 7
- 229960005542 ethidium bromide Drugs 0.000 description 7
- 241000699800 Cricetinae Species 0.000 description 6
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 6
- 230000002068 genetic effect Effects 0.000 description 6
- 239000000758 substrate Substances 0.000 description 6
- 108091092919 Minisatellite Proteins 0.000 description 5
- 230000003321 amplification Effects 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 239000003398 denaturant Substances 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 238000003199 nucleic acid amplification method Methods 0.000 description 5
- 229920002401 polyacrylamide Polymers 0.000 description 5
- 239000004677 Nylon Substances 0.000 description 4
- 238000001962 electrophoresis Methods 0.000 description 4
- 229920001778 nylon Polymers 0.000 description 4
- 108091008146 restriction endonucleases Proteins 0.000 description 4
- 238000010186 staining Methods 0.000 description 4
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 3
- 108700028369 Alleles Proteins 0.000 description 3
- 241000282412 Homo Species 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 3
- 239000004202 carbamide Substances 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 230000003252 repetitive effect Effects 0.000 description 3
- 241000894007 species Species 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 102000053602 DNA Human genes 0.000 description 2
- 208000028782 Hereditary disease Diseases 0.000 description 2
- 208000026350 Inborn Genetic disease Diseases 0.000 description 2
- 208000024556 Mendelian disease Diseases 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 238000002105 Southern blotting Methods 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 238000004925 denaturation Methods 0.000 description 2
- 230000036425 denaturation Effects 0.000 description 2
- 239000010439 graphite Substances 0.000 description 2
- 229910002804 graphite Inorganic materials 0.000 description 2
- 238000013507 mapping Methods 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- 238000007894 restriction fragment length polymorphism technique Methods 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 241000699802 Cricetulus griseus Species 0.000 description 1
- 230000007023 DNA restriction-modification system Effects 0.000 description 1
- SHIBSTMRCDJXLN-UHFFFAOYSA-N Digoxigenin Natural products C1CC(C2C(C3(C)CCC(O)CC3CC2)CC2O)(O)C2(C)C1C1=CC(=O)OC1 SHIBSTMRCDJXLN-UHFFFAOYSA-N 0.000 description 1
- WGZDBVOTUVNQFP-UHFFFAOYSA-N N-(1-phthalazinylamino)carbamic acid ethyl ester Chemical compound C1=CC=C2C(NNC(=O)OCC)=NN=CC2=C1 WGZDBVOTUVNQFP-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 108010006785 Taq Polymerase Proteins 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 238000004873 anchoring Methods 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 238000000211 autoradiogram Methods 0.000 description 1
- 238000000376 autoradiography Methods 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 1
- SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 1
- RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 1
- HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 description 1
- NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- QONQRTHLHBTMGP-UHFFFAOYSA-N digitoxigenin Natural products CC12CCC(C3(CCC(O)CC3CC3)C)C3C11OC1CC2C1=CC(=O)OC1 QONQRTHLHBTMGP-UHFFFAOYSA-N 0.000 description 1
- 230000005684 electric field Effects 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 238000012252 genetic analysis Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- ZIUHHBKFKCYYJD-UHFFFAOYSA-N n,n'-methylenebisacrylamide Chemical compound C=CC(=O)NCNC(=O)C=C ZIUHHBKFKCYYJD-UHFFFAOYSA-N 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 210000004940 nucleus Anatomy 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 230000002572 peristaltic effect Effects 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 102000054765 polymorphisms of proteins Human genes 0.000 description 1
- 230000037452 priming Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000000392 somatic effect Effects 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6858—Allele-specific amplification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Definitions
- TITLE Method of detecting DNA sequence variation.
- This invention relates to a method of detecting genetic variation by subjecting DNA fragments, derived from a DNA sample to be analyzed, to a two-dimensional electrophoretic separation, with the fragments being separated in one dimension on the basis of differences in length and in the other dimension on the basis of differences in base sequence, transferring the resultant separation pattern to a membrane filter and subjecting the transferred separation pattern to a hybridization analysis using one or more DNA or RNA probes.
- DNA diagnostics i.e. the use of methods for demonstrating genetic variation at those sites which may be an indication for certain properties, such as susceptibility to certain diseases and other medically and economically important characteristics.
- genetic variation refers to differences between individuals in the base pair sequence of their DNA.
- RFLP restriction fragment length polymorphism
- Probes which detect polymorphic DNA sequences can be used in a comparable manner in plant improvement and in the breeding of cattle and other economically important animals. The point is that if it is known that a particular DNA variant is always inherited together with a particular property, the presence or absence of that property can be determined at an early stage which is of great importance for improvement because in this way the generation interval can be avoided (this principle is called "Marker Assisted Selection”) .
- VNTR-type sequences occur in humans much more often at the telomeres (terminal ends of the chromosome) than elsewhere (Royle et al., 1989) .
- telomeres terminal ends of the chromosome
- other VNTR-type sequences not much is known about this and also in animal species other than man and in plants there is only little information about the occurrence and distribution of VNTR-type sequences.
- a third point concerns the fact that only 20-50% of the sequences detected by the core probes are polymorphic and, accordingly, useful for the analysis. In other words, the majority of the spots cannot be used for mapping and only takes up space in the separation pattern. It would therefore be much better to use sequences which occur once at least about every 2 million base pairs, are nearly always polymorphic and are equally distributed over the genome.
- a sequence with these properties is for example the repetitive element Alu.
- PDJ33A 5*-GGATCCGCCTCCCAAAGTGCTGGGATTACAGG-3 •
- the present invention provides a method for detecting genetic variation by subjecting DNA fragments derived from a DNA sample to be examined by two-dimensional electrophoretic separation, with the fragments being separated in one dimension on the basis of differences in length and in the other dimension on the basis of differences in base sequence, transferring the resultant separation pattern to a membrane filter and subjecting the transferred separation pattern to a hybridization analysis using one or more DNA or RNA probes, which method is characterized by using DNA fragments which consist of one or more inter-repeat sequences which on the basis of the DNA to be examined have been generated by means of a DNA amplification process such as the polymerase chain reaction (PCR) with repeat-specific primer(s).
- PCR polymerase chain reaction
- a very important preferred embodiment of the invention is characterized in that in the hybridization analysis, as a probe use is made of one or more inter-repeat sequences which have been generated by means of an amplification process such as a PCR with repeat-specific primer(s), performed on subgenomic DNA, for instance DNA of one chromosome or a part thereof.
- an amplification process such as a PCR with repeat-specific primer(s), performed on subgenomic DNA, for instance DNA of one chromosome or a part thereof.
- the invention makes it possible to detect genetic variation on specific chromosomes or parts thereof, using a selective amplification of double-stranded DNA in specific sites, occurring at least every 2 million base pairs, an electrophoretic separation of the amplification products in two dimensions, transfer of the separation pattern to a membrane filter, followed by a hybridization with labelled DNA fragments which may come from (a) cloned DNA such as cosmid and YAC (yeast artificial chromosome) clones, or (b) chromosomes or parts thereof such as obtained after flow-sorting chromosomes or such as are present in a human-hamster somatic cell hybrid.
- cloned DNA such as cosmid and YAC (yeast artificial chromosome) clones
- chromosomes or parts thereof such as obtained after flow-sorting chromosomes or such as are present in a human-hamster somatic cell hybrid.
- the DNA to be examined will mostly consist of the DNA of a complete genome of an animal or plant, and the most important applications will concern human DNA.
- inter-Alu PCR coupled with 2-D DNA typing, could be used for genome scanning in a way that is superior in at least two respects to the previously described genetic analysis with an electrophoretic separation of the restriction fragments in two dimensions and a hybridization with GC-rich minisatellite core probes.
- the inter-Alu method enables, after a two-dimensonal separation of the fragments which have been generated with total genomic DNA as substrate, recognition of certain specific regions in the genome by hybridization with a probe mixture consisting of inter-Alu PCR products which come from a specific chromosome (obtained through flow sorting or as hybrid cell line) or a part thereof, for instance in the form of cosmid or YAC clones.
- a 2-D separation pattern of inter-Alu PCR products coming from total genomic DNA of different individuals can directly provide information about genetic differences and similarities, namely specifically for certain chromosomes or parts thereof, depending on the probe mixture used.
- probe mixtures may for instance serve inter- Alu products originating from human-hamster hybrid cell lines which contain one or more human chromosomes or parts thereof.
- the DNAs in question can be labeled and subsequently used as hybridization probe for the analysis of 2-D separation patterns of inter-Alu amplification products (for lack of homology, the hamster DNA will not bind) .
- This will result in an individual- specific stain pattern, each stain being in principle a variant of an inter-Alu DNA fragment which is located in the region that is specified by the human chromosome (or a part thereof) present in the hybrid cell line.
- the label used for the probe is not in itself critical and all known labels for DNA or RNA probes can be used.
- the probe that is used in the hybridization analysis can be labelled with a radioisotope such as 32 P and 35 S, with a hapten such as biotin and digoxigenin, with a fluorescent substance or with a combination of such labels.
- the method described hereinabove can be used in the determination of genetic variation in any animal or plant species, provided that individual chromosomes or parts thereof are available, for instance in the form of flow-sorted chromosomes, hybrid cell lines (in which case the DNA of the other species should have no homology with the "Alu-like" priming sites in the DNA of the species to be examined) and cosmid or YAC clones.
- the method confined to the Alu or Alu-like repeat family, but it can also been used on other human repeat families, such as the Kpn family (see Ledbetter et al., 1990a; see further Table 2 for an overview of Kpn specific primers and Fig.
- the method can be used to screen within a short time a large number of polymorphic sites in a priorly defined region within a chromosome, for individual differences, which information can be used directly to obtain a marker for a hereditary characteristic, such as a hereditary disease.
- a hereditary characteristic such as a hereditary disease.
- An alternative is to locate beforehand all spots (inter-Alu variants) which can be found in a 2-D chromosome-specific DNA scan and to reduce them to a specific recombinant DNA clone in one of the reference libraries open to the public.
- the setting up of such a database of polymorphic DNA sequences as spots in a 2-D separation pattern is discussed extensively in Uitterlinden and Vijg, 1989 and EP-A-0349024.
- the invention then, relates to the following:
- Electrophoretic separation in 2 dimensions i.e. size and base pair composition
- inter-repeat PCR products obtained from total genomic DNA from a human, animal or plant using one or more primers specific for one or more repetitive sequences.
- PCR reaction was performed, using PCR primer TC65.
- the primer was synthesized on a Gene Assembler Plus (Pharmacia, Sweden) and was used directly after the deprotection-isolation step, without further purification.
- the sequence of this primer consisting of 30 nucleotides, is 5 « -AAGTCGCGGCCGCTTGCAGTGAGCCGAGAT-3' (see also Nelson et al., 1989) .
- the PCR reactions were performed in a total volume of 50 ⁇ l (microlitre) containing 400 ng genomic DNA, 1 ⁇ M primer TC65, 50 mM KC1, 10 mM Tris.HCl pH 8.0, 1.5 mM MgCl , 200 ⁇ M dATP, 200 ⁇ M dTTP, 200 ⁇ M dCTP, 200 ⁇ M dGTP and 1 unit of Taq polymerase (Gibco-BRL, Bethesda, Maryland, USA) .
- a total of 30 cycli were traversed, each cycle comprising successively 2 min denaturation at 95°C, 1 min annealing at 60°C, and 4 min extension at 72°C.
- the first denaturation step was prolonged by 5 min and the final extension step was prolonged by 4 min.
- the genomic DNA samples used were Chinese Hamster Ovary (CHO) total genomic DNA and Hela human total genomic DNA, and CHO-human somatic cell hybrid genomic DNA from the following cell lines: 643C-13, 21q+, R2-10W, ACEM, 2Fur-l, 72532X-6, and 153E7b (see Gardiner et al., 1990) .
- 5A shows the human chromosome 21 complement of these hybrids.
- Electrophoresis (2 h and 250 volts) was done in lxTAE (40 mM Tris.HCl pH 7.4, 20 mM Na-acetate, 1 mM Na-EDTA) at 50°C.
- the separation pattern was visualized by staining with ethidium bromide (0.1 ⁇ g per ml) and decolouring in water for 30 min.
- 5B shows that the TC65 PCR reaction is specific for human DNA since no colouring occurs in the lane with PCR products of total genomic hamster DNA.
- a smear is visible with a single band therein. This is due to the very large number of different inter-Alu products originating from all human chromosomes together.
- discrete bands are visible. Since these hybrids only have the human chromosome 21, these bands must originate from inter-Alu regions on the human chromosome 21.
- the band patterns are mutually different, which is a reflection of the different pieces of chromosome 21 which the cell line in question contains (see Fig. 5A) . In this way specific bands can be identified as originating from specific regions on the chromosome.
- a TC65 PCR reaction was performed, now with genomic DNA of the cell line 72532X6 as a substrate being compared with Hela human genomic DNA.
- 25 ⁇ l of the two reaction products was separated on a PAA gel as described above. After staining of this 1-D separation pattern, the fragments with a length of between 10 kilo base pairs (kb) and 600-base pairs (bp) were excised as lanes and transferred to a 2-D PAA gel.
- the 2-D gel was a 1 mm thick 6% PAA gel (see above) which contained a 10-75% linear gradient of the denaturants urea and formamide (100% denaturants corresponds to 7.0 M urea, 40% formamide) parallel to the direction of the electrophoresis.
- the gels were prepared by mixing the two solutions with the two most extreme denaturant concentrations, which determine the range of the gradient, in a gradient mixer (Gibco-BRL) using a peristaltic pump (LKB, Sweden) .
- the electrophoresis for the second dimension separation was performed at 55°C in lxTAE, for 12 h. After completion of the separation, the 2-D gel was stained as described above (see Fig. 6) .
- the separation pattern of 72532X6 demonstrates that the TC65 inter-Alu PCR fragments focus as spots in the 2-D gel. At the place where the TC65 inter-Alu PCR products of total genomic human Hela DNA are located, nothing is to be seen on gel because the concentration of individual PCR fragments is too low to be demonstrated by ethidium bromide staining. To visualize these fragments, the 2-D separation pattern was transferred to a nylon membrane (Hybond N-plus, Amersham, UK) by means of electroblotting between horizontal graphite plates with the anode at the top (see also Vijg and Uitterlinden, EP-A-0 349 024) .
- the 2-D gel was first irradiated for 4 min with UV light of 302 nm (Transilluminator, UV products, CA, USA) .
- the gel was placed on the nylon membrane and subsequently placed on opposite sides between three Whatmann 3MM paper leaves which had been saturated with IxTBE (89 mM Tris.borate pH 8.0, 89 mM boric acid, 2 mM Na-EDTA) .
- IxTBE 89 mM Tris.borate pH 8.0, 89 mM boric acid, 2 mM Na-EDTA
- the nylon membrane was placed on a leaf of Whatmann 3MM which had been saturated with 0.4 N sodium hydroxide and subsequently placed in the 1 M Tris.HCl pH 8.0 for 10 min for neutralization, so as to make the DNA fragments on the membrane single-stranded.
- the membrane was dried in air and subsequently irradiated with 302 nm UV to bind the DNA fragments to the membrane by cross-linking.
- This membrane was subsequently subjected to hybridization analysis wherein as a probe use was made of 3 ⁇ l of the TC65 inter-Alu PCR mixture obtained with 72532X6 as substrate (and of which 25 ⁇ l in the first dimension was separated on gel, see Figs. 5 and 6) .
- this labelled probe mixture was made single-stranded by boiling it for 5 min and it was subsequently preincubated with 200 ⁇ g partly degraded human DNA in a total volume of 1 ml at 65°C for 1 h, so as to repress cross hybridization with the Alu repeats themselves and to allow only the inter-Alu sequences to hybridize.
- Hybridization analysis was performed in glass tubes in a hybridization oven (GFL, Germany) at 65°C.
- the membrane was first preincubated for 15 min in the hybridization fluid which consisted of 7% SDS, 0.5 M Na-phosphate pH 7.2, 1 mM Na-EDTA. Then the labelled and preincubated 72532X6 TC65 inter-Alu probe was added and the hybridization reaction took place for 16 h. Then the membrane was successively washed in
- Fig. 7 shows that after hybridization the same separation pattern for the 72532X6 TC65 inter-Alu PCR products was visualized as what we observed after ethidium bromide staining. Of greater importance is the fact that we can also observe spots at the place of the Hela TC65 inter-Alu products.
- FIG. 8 shows that multiple spots were visible after autoradiography in the 2-D separation pattern of inter-repeat products obtained from human total genomic DNA, indicating the possibility to scan several different inter- repeat sequences in the human genome.
- inter-repeat primers can be used which are specific for repeats located in the centromeres, such as the alphoid satellite repeats (LI.26 and others) .
- these primers are used in combination with Alu and/or Kpn primers in experiments similar to experiments 1, 2 and 3, band patterns can be obtained (see Fig. 10) which are comparable with those shown in Figs. 5 and 9.
- Fig, 1 Two-dimensional separation pattern, generated using minisatellite core probe 33.6 of human Haelll DNA restriction fragments originating from a mother (circle) , father (square on the right) and their son (square in the middle) .
- A Schematic overview of the composition as to the chromosome 21 contents of human-hamster somatic cell hybrids used for the inter-repeat PCR amplifications.
- B Ethidium bromide-stained one-dimensional separation pattern of the PCR products, obtained after an inter-Alu PCR amplification using primer TC65 on the members of the somatic hybrid panel shown in 5A and on total hamster genomic DNA and totale human genomic DNA. Fi ⁇ . 6
- FIG. 7 Autoradiograms (A is the short and B is the long irradiation) of a two-dimensional separation pattern of inter- Alu PCR amplifications with primer TC65 of human total genomic DNA (Hela) and of the somatic cell hybrid 72532X6. Arrows designate spots in the Hela separation pattern after the long irradiation, which can be recognized at a similar location in the 72532X6 pattern.
- Ethidium bromide-stained one-dimensional separation pattern of inter-repeat PCR amplification products obtained with a combination of the Alu-specific primer TC65 with the Kpn-specific PCR primers KpnA, -B, -C, and -D, the substrate being total hamster genomic DNA and DNA from the somatic cell hybrid 72532X6.
- Ethidium bromide-stained one-dimensional separation pattern of inter-repeat PCR amplification products obtained with the Alu-specific primers 517 and TC65 in combination with the Kpn-specific primers KpnA, -B, -C, and -D and in combination with the chromosome 21-specific centromere primers 26.5B, 26W and 26.3, the substrate being total hamster genomic DNA and DNA from the somatic cell hybrid 153E7b.
- Gardiner K. Horisberger, M., Kraus, J., Tantravahi, U., Korenberg, J., Rao, V., Reddy, S., and Patterson, D. (1990) EMBO J. 9, 25-34.
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NL9100132 | 1991-01-25 | ||
NL9100132A NL9100132A (nl) | 1991-01-25 | 1991-01-25 | Werkwijze voor het detecteren van dna sequentievariatie. |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1992013101A1 true WO1992013101A1 (fr) | 1992-08-06 |
Family
ID=19858781
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/NL1992/000018 WO1992013101A1 (fr) | 1991-01-25 | 1992-01-24 | Procede de detection de la variation de sequences d'adn |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP0559841A1 (fr) |
NL (1) | NL9100132A (fr) |
WO (1) | WO1992013101A1 (fr) |
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994003640A1 (fr) * | 1992-07-31 | 1994-02-17 | Government Of The United States As Represented By Secretary Department Of Health And Human Services | Onze marqueurs d'adn polymorphes a repetition de microsatellites extremement instructifs |
WO1994012669A3 (fr) * | 1992-11-30 | 1994-07-21 | Genetics Inst | Detection d'adn contaminants par polymerisation en chaine |
US5369004A (en) * | 1991-05-29 | 1994-11-29 | The United States Of America As Represented By The Department Of Health And Human Services | Five highly informative microsatellite repeat polymorphic DNA markers |
WO1995017522A3 (fr) * | 1993-12-21 | 1995-11-02 | Univ Leicester | Identification de sequences repetees simples en tandem |
WO1996000796A1 (fr) * | 1994-06-28 | 1996-01-11 | Ingeny B.V. | Procede de detection de mutations |
WO1996039535A1 (fr) * | 1995-06-06 | 1996-12-12 | Jan Vijg | Procede et dispositif pour test diagnostique d'adn |
WO1996034979A3 (fr) * | 1995-05-01 | 1997-01-03 | Rech Hopital Sainte Justine | Amorces et procedes d'amplification simultanee de marqueurs multiples pour l'etablissement d'empreintes proteiques d'adn |
WO1996010648A3 (fr) * | 1994-09-30 | 1997-02-27 | Promega Corp | Amplification multiplex et loci courts repetes en tandem |
EP0714987A3 (fr) * | 1994-09-26 | 1997-03-26 | Immuno Ag | Procédé pour quantifier d'ADN génomiques |
US5698686A (en) * | 1994-10-20 | 1997-12-16 | Arch Development Corporation | Yeast telomerase compositions |
EP0809103A3 (fr) * | 1996-03-28 | 2000-06-07 | Fmc Corporation | Dénaturants stables pour l'utilisation en techniques électrophorétiques et méthodes d'utilisation |
WO2004018691A1 (fr) * | 2002-08-22 | 2004-03-04 | The University Of Hong Kong | Procede pour adn chromosomique micro-excise d'amplification et son utilisation |
WO2004027089A1 (fr) * | 2002-09-12 | 2004-04-01 | Alopex Gmbh | Procede d'amplification d'informations genetiques |
EP1375516A3 (fr) * | 1997-08-06 | 2004-06-09 | Genset | Méthode de production d'un polypeptide recombinant du récepteur LSR |
US7306912B2 (en) * | 2002-02-25 | 2007-12-11 | Lifeind Ehf. | Method for two-dimensional conformation-dependent separation of non-circular nucleic acids |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101792808A (zh) * | 2010-03-30 | 2010-08-04 | 广州市香港科大霍英东研究院 | 以Alu间聚合酶链式反应为基础的检测基因区特征的方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0349024A1 (fr) * | 1988-05-02 | 1990-01-03 | Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno | Un procédé pour la détermination simultanée des variations de la séquence d'ADN, et un kit à cet effet |
-
1991
- 1991-01-25 NL NL9100132A patent/NL9100132A/nl not_active Application Discontinuation
-
1992
- 1992-01-24 WO PCT/NL1992/000018 patent/WO1992013101A1/fr not_active Application Discontinuation
- 1992-01-24 EP EP92904579A patent/EP0559841A1/fr not_active Withdrawn
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0349024A1 (fr) * | 1988-05-02 | 1990-01-03 | Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno | Un procédé pour la détermination simultanée des variations de la séquence d'ADN, et un kit à cet effet |
Non-Patent Citations (6)
Title |
---|
Genomics, vol. 6, no. 3, March 1990, Academic Press, Inc., S.A. LEDBETTER et al.: "Rapid isolation of DNA probes within specific chromosome regions by interspersed repetitive sequence polymerase chain reaction", pages 475-481, see page 476 (cited in the application) * |
Nucleic Acids Research, vol. 18. no. 10, 16 March 1990, C. BREUKEL et al.: "Vector-Alu PCR: a rapid step in mapping cosmids and YACs", page 3097, see the whole document * |
Proc. Natl. Acad. Sci. USA, vol. 86, April 1989, A.G. UITTERLINDEN et al.: "Two-dimensional DNA fingerprinting of human individuals", pages 2742-2746, see the whole document (cited in the application) * |
Proc. Natl. Acad. Sci. USA, vol. 86, September 1989, D.L. NELSON et al.: "Alu polymerase chain reaction: A method for rapid isolation of human-specific sequences from complex DNA sources", pages 6686-6690, see page 6686 (cited in the application) * |
Proc. Natl. Acad. Sci. USA, vol. 87, September 1990, P. LICHTER et al.: "Fluorescence in situ hybridization with Alu and L1 polymerase chain reaction probes for rapid characterization of human chromosomes in hybrid cell lines", pages 6634-6638, see the whole document (cited in the application) * |
Tibtech, vol. 7, December 1989, Elsevier Science Publishers Ltd, (GB), A.G. UITTERLINDEN et al.: "Two-dimensional DNA typing", page 336-341, see page 339 (cited in the application) * |
Cited By (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5861504A (en) * | 1991-05-29 | 1999-01-19 | The United States Of America As Represented By The Department Of Health And Human Services | Eleven highly informative microsatelite repeat polymorphic DNA markers |
US5369004A (en) * | 1991-05-29 | 1994-11-29 | The United States Of America As Represented By The Department Of Health And Human Services | Five highly informative microsatellite repeat polymorphic DNA markers |
WO1994003640A1 (fr) * | 1992-07-31 | 1994-02-17 | Government Of The United States As Represented By Secretary Department Of Health And Human Services | Onze marqueurs d'adn polymorphes a repetition de microsatellites extremement instructifs |
AU673850B2 (en) * | 1992-07-31 | 1996-11-28 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | Eleven highly informative microsatellite repeat polymorphic DNA markers |
WO1994012669A3 (fr) * | 1992-11-30 | 1994-07-21 | Genetics Inst | Detection d'adn contaminants par polymerisation en chaine |
US5393657A (en) * | 1992-11-30 | 1995-02-28 | Genetics Institute, Inc. | Detection of residual host cell DNA by PCR |
WO1995017522A3 (fr) * | 1993-12-21 | 1995-11-02 | Univ Leicester | Identification de sequences repetees simples en tandem |
US5843647A (en) * | 1993-12-21 | 1998-12-01 | University Of Leicester | Simple tandem repeats |
NL9401082A (nl) * | 1994-06-28 | 1996-02-01 | Ingeny Bv | Werkwijze voor het detecteren van mutaties. |
WO1996000796A1 (fr) * | 1994-06-28 | 1996-01-11 | Ingeny B.V. | Procede de detection de mutations |
US5858658A (en) * | 1994-09-26 | 1999-01-12 | Immuno Aktiengesellschaft | Method of quantitating genomic DNA |
EP0714987A3 (fr) * | 1994-09-26 | 1997-03-26 | Immuno Ag | Procédé pour quantifier d'ADN génomiques |
WO1996010648A3 (fr) * | 1994-09-30 | 1997-02-27 | Promega Corp | Amplification multiplex et loci courts repetes en tandem |
US5698686A (en) * | 1994-10-20 | 1997-12-16 | Arch Development Corporation | Yeast telomerase compositions |
US5916752A (en) * | 1994-10-20 | 1999-06-29 | Arch Development Corporation | Telomerase screening methods |
US6387619B1 (en) | 1994-10-20 | 2002-05-14 | Arch Development | Telomerase compositions and methods |
WO1996034979A3 (fr) * | 1995-05-01 | 1997-01-03 | Rech Hopital Sainte Justine | Amorces et procedes d'amplification simultanee de marqueurs multiples pour l'etablissement d'empreintes proteiques d'adn |
US5814491A (en) * | 1995-06-06 | 1998-09-29 | Vijg; Jan | Method of and apparatus for diagnostic DNA testing |
WO1996039535A1 (fr) * | 1995-06-06 | 1996-12-12 | Jan Vijg | Procede et dispositif pour test diagnostique d'adn |
EP0809103A3 (fr) * | 1996-03-28 | 2000-06-07 | Fmc Corporation | Dénaturants stables pour l'utilisation en techniques électrophorétiques et méthodes d'utilisation |
EP1375516A3 (fr) * | 1997-08-06 | 2004-06-09 | Genset | Méthode de production d'un polypeptide recombinant du récepteur LSR |
US7306912B2 (en) * | 2002-02-25 | 2007-12-11 | Lifeind Ehf. | Method for two-dimensional conformation-dependent separation of non-circular nucleic acids |
WO2004018691A1 (fr) * | 2002-08-22 | 2004-03-04 | The University Of Hong Kong | Procede pour adn chromosomique micro-excise d'amplification et son utilisation |
WO2004027089A1 (fr) * | 2002-09-12 | 2004-04-01 | Alopex Gmbh | Procede d'amplification d'informations genetiques |
Also Published As
Publication number | Publication date |
---|---|
EP0559841A1 (fr) | 1993-09-15 |
NL9100132A (nl) | 1992-08-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Orita et al. | DNA sequence polymorphisms in Alu repeats | |
EP0349024B1 (fr) | Un procédé pour la détermination simultanée des variations de la séquence d'ADN, et un kit à cet effet | |
WO1992013101A1 (fr) | Procede de detection de la variation de sequences d'adn | |
US5599666A (en) | Allelic ladders for short tandem repeat loci | |
Giacalone et al. | A novel GC–rich human macrosatellite VNTR in Xq24 is differentially methylated on active and inactive X chromosomes | |
McKay et al. | The identification of a repeated DNA sequence involved in the karyotype polymorphism of the human Y chromosome | |
CA2302432A1 (fr) | Normes de compatibilite pour un locus d'encadrement de l'adn utilise en electrophorese | |
Witney et al. | Highly repeated DNA families in the rat. | |
Barton et al. | Localization of the human α-globin gene cluster to the short arm of chromosome 16 (16p12–16pter) by hybridization in situ | |
Baechtel et al. | Multigenerational amplification of a reference ladder for alleles at locus D1S80 | |
Ellegren et al. | Integrating the porcine physical and linkage map using cosmid‐derived markers | |
Zoghbi et al. | Sixty-five radiation hybrids for the short arm of human chromosome 6: their value as a mapping panel and as a source for rapid isolation of new probes using repeat element-mediated PCR | |
US5032502A (en) | Purification of polymorphic components of complex genomes | |
Eubanks et al. | Isolation, localization, and physical mapping of a highly polymorphic locus on human chromosome 11q13 | |
WO1996034979A2 (fr) | Amorces et procedes d'amplification simultanee de marqueurs multiples pour l'etablissement d'empreintes proteiques d'adn | |
Simmler et al. | Adaptation of the interspersed repetitive sequence polymerase chain reaction to the isolation of mouse DNA probes from somatic cell hybrids on a hamster background | |
Segal et al. | In situ hybridization of repetitive monkey genome sequences isolated from defective simian virus 40 DNA | |
Kwiatkowski Jr et al. | Linkage mapping and fluorescence in situ hybridization of TCTE1 on human chromosome 6p: analysis of dinucleotide polymorphisms on native gels | |
Burmeister et al. | Identification of polymorphisms by genomic denaturing gradient gel electrophoresis: application to the proximal region of human chromosome 21 | |
Uitterlinden | Two-dimensional DNA typing: A parallel approach to genome analysis | |
Warren et al. | Detection of mutations by single‐strand conformation polymorphism (SSCP) analysis and SSCP‐hybrid methods | |
Barros et al. | Electrophoretic human leukocyte antigen HLA‐DQA1 DNA typing after polymerase chain reaction amplification | |
Uitterlinden et al. | Genome scanning by two‐dimensional DNA typing: The use of repetitive DNA sequences for rapid mapping of genetic traits | |
Barros et al. | Detection of polymorphisms of human DNA after polymerase chain reaction by miniaturized SDS-PAGE | |
Sheppard et al. | Two-dimensional gel analysis of complex DNA families: methodology and apparatus |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): CA US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IT LU MC NL SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1992904579 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1992904579 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref country code: US Ref document number: 1993 90154 Date of ref document: 19930916 Kind code of ref document: A Format of ref document f/p: F |
|
NENP | Non-entry into the national phase |
Ref country code: CA |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1992904579 Country of ref document: EP |